Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 2 Trials for DCFPyL F-18 (DB14805)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0317392418F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate CancerDiagnostic
NCT0318186718F-DCFPyL PET/CT in High Risk and Recurrent Prostate CancerDiagnostic